La Jolla Labs
High-throughput screening technology for RNA drug discovery
Operating in nfx portfolio, La Jolla Labs was founded in 2020.
La Jolla Labs is positioned in nfx portfolio, a segment that rewards a clear, focused offering.
Its current recorded stage is Seed.
| Sector | NFX portfolio |
|---|---|
| Founded | 2020 |
| Stage | Seed |
Website: lajollalabs.com
Browse related
Sign in to view the contact information we hold for La Jolla Labs.
Create a free account
Create a free account